Home/Filings/4/0001209191-06-034720
4//SEC Filing

LANKAU PETER A 4

Accession 0001209191-06-034720

CIK 0001100962other

Filed

Jun 4, 8:00 PM ET

Accepted

Jun 5, 6:37 PM ET

Size

16.0 KB

Accession

0001209191-06-034720

Insider Transaction Report

Form 4
Period: 2006-06-01
LANKAU PETER A
SVP, US Business
Transactions
  • Exercise/Conversion

    Stock options granted pursuant to 2000 Stock Incentive Plan

    2006-06-0143,652351,911 total
    Common Stock (43,652 underlying)
  • Exercise/Conversion

    Common Stock, par value $.01 per share

    2006-06-01+43,6521,244,827 total
  • Sale

    Common Stock, par value $.01 per share

    2006-06-01$29.60/sh43,652$1,291,9461,201,175 total
Footnotes (7)
  • [F1]Of the 43,652 shares sold here, 8,174 were underlying stock options with an exercise price of $7.25 per share, 27,389 were underlying stock options with an exercise price of $9.40 per share and 8,089 were underlying stock options with an exercise price of $9.17 per share.
  • [F2]Mr. Lankau's beneficial ownership includes 67,399 shares of Endo common stock and 1,177,428 shares underlying options granted under the Endo Pharmaceuticals Holdings Inc. 2000 and 2004 Stock Incentive Plans, 480,791 of which are currently exercisable.
  • [F3]As previously disclosed, Mr. Lankau had placed 436,520 of the shares underlying his stock options into a 10b5-1 pre-set selling program for a period of approximately 24 months, which began on March 1, 2006 (the "Lankau Pre-Set Selling Program"). The shares sold here were sold pursuant to the Lankau Pre-Set Selling Program, which leaves 261,912 shares (underlying options) in the Lankau Pre-Set Selling Program as of June 5, 2006.
  • [F4]Mr. Lankau's beneficial ownership includes 23,747 shares of Endo common stock and 1,177,428 shares underlying options granted under the Endo Pharmaceuticals Holdings Inc. 2000 and 2004 Stock Incentive Plans, 480,791 of which are currently exercisable. The 43,652 shares sold here were sold pursuant to the Lankau Pre-Set Selling Program, which leaves 261,912 shares (underlying options) in the Lankau Pre-Set Selling Program as of June 5, 2006.
  • [F5]Of the 43,652 shares sold here, 8,174 of the related stock options were exercisable on 10/13/2004, 6,847 of the related stock options were exercisable on 8/8/2002, 6,847 of the related stock options were exercisable on 8/8/2003, 6,847 of the related stock options were exercisable on 8/8/2004, 6,848 of the related stock options were exercisable on 8/8/2005, and 8,089 of the related stock options were exercisable on 9/19/2003.
  • [F6]Of the 43,652 shares sold here, 8,174 were underlying stock options with an expiration date of 10/13/2010, 27,389 were underlying stock options with an expiration date of 8/8/2011 and 8,089 were underlying stock options with an expiration date of 9/19/2012.
  • [F7]This number represents the remainder of the 9/19/2002 grant to Mr. Lankau of 360,000 options.

Issuer

ENDO PHARMACEUTICALS HOLDINGS INC

CIK 0001100962

Entity typeother

Related Parties

1
  • filerCIK 0001179354

Filing Metadata

Form type
4
Filed
Jun 4, 8:00 PM ET
Accepted
Jun 5, 6:37 PM ET
Size
16.0 KB